Novo Nordisk Secures EU Approval for Oral Wegovy
BAGSVÆRD, Denmark, July 15, 2026 Novo Nordisk has achieved a major regulatory milestone after the European Commission (EC) granted...
CHMP
Advertisement
Sanofi Nexviazyme Delivers Positive Phase 3 Pompe Trial Results
PARIS, June 30, 2026 Sanofi has announced that its enzyme replacement therapy Nexviazyme® (avalglucosidase alfa) successfully met all primary...
Zambon Hopledo® Wins CHMP Backing for Parkinson’s Disease
BRESSO, Milan, Italy, June 29, 2026 Zambon has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Roche Enspryng Gains FDA Priority Review for TED Treatment
BASEL, Switzerland, June 30, 2026 Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
AbbVie RINVOQ® Moves Closer to EU Approval for Alopecia Areata
NORTH CHICAGO, Ill., June 29, 2026 AbbVie has announced that the European Medicines Agency’s Committee for Medicinal Products for...
Advertisements
Acadia’s DAYBU Recommended for EU Approval in Rett Syndrome
SAN DIEGO, June 26, 2026 Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of...
AstraZeneca, Daiichi Sankyo Advance Datroway Toward EU Approval
CAMBRIDGE, UK & TOKYO, Japan, June 26, 2026 AstraZeneca and Daiichi Sankyo have moved one step closer to expanding...
Everest Medicines Eyes China Approval for LEROCHOL® PCSK9 Therapy
SHANGHAI, China, June 26, 2026 Everest Medicines announced a significant regulatory milestone after China’s National Medical Products Administration (NMPA)...
Lilly Jaypirca CHMP Backs EU Approval for CLL Treatment
INDIANAPOLIS, June 26, 2026 Eli Lilly and Company announced that the European Medicines Agency’s Committee for Medicinal Products for...
MaaT Pharma to Seek EMA Re-Examination for Xervyteg After CHMP Rejection
LYON, France, June 26, 2026 MaaT Pharma announced plans to request a re-examination of the European Medicines Agency (EMA)...
Advertisement
